Clinical Trials Browser

Has results × Breast Neoplasms × tipifarnib × Clear all

NCT00470301 2021-02-16

Tipifarnib and Combination Chemotherapy in Treating Patients With Stage II or Stage III Breast Cancer

Phase 1/2 Completed

60 enrolled 6 charts

Breast Neoplasms, Breast Neoplasms, Male

NCT00082810 2018-11-01

Tipifarnib and Fulvestrant in Hormone Receptor-Positive Metastatic Breast Cancer

Phase 2 Completed

33 enrolled 10 charts

Breast Neoplasms